Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises the Erik Thun Group in connection with a shipping transaction with A.P. Möller Maersk
Mandate

Vinge advises the Erik Thun Group in connection with a shipping transaction with A.P. Möller Maersk

October 25, 2012

Vinge is advising the Erik Thun Group in connection with the acquisition of 13 oil and chemicals tankers from the A.P. Möller Maersk Group. The tankers are included in the Small Tanker Northwest Europe (8000 dwt) operational category and twelve are included in Dutch shipping companies jointly owned by Maersk and Thun. In connection with the acquisition, the Erik Thun Group will also acquire the salient parts of Broström AB’s business in Gothenburg which handle tanker maintenance and the employees in question will be offered employment.

Closing in respect of the transaction is conditional upon the consent of the Norwegian Competition Authority.

Vinge’s team consists of responsible partner Anders Strid, associates Anna Palmérus (competition) and Patrik Gargolinski (M&A).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025